Investing

Explore our collection of articles about Investing.

More Articles

Beginner’s Guide to Purchasing Cannabis Stocks
Investing

Beginner’s Guide to Purchasing Cannabis Stocks

Investing in cannabis companies has transitioned from a specialized niche to a more conventional opportunity over the last ten years,

Read
Black Swift Group Sells 3,405 MercadoLibre Shares for $8M
Investing

Black Swift Group Sells 3,405 MercadoLibre Shares for $8M

Key Points Black Swift Group, LLC completely divested its holdings in MercadoLibre by selling 3,405 shares during the fourth quarter.

Read
6 Top Stock Picks for the Next 5 Years
Investing

6 Top Stock Picks for the Next 5 Years

Motley Fool co-founder and CEO Tom Gardner engages in an insightful discussion with Chief Investment Officer Andy Cross about promising

Read
Payoneer: Hidden Payments Gem or Risky Investment?
Investing

Payoneer: Hidden Payments Gem or Risky Investment?

Payoneer Global, trading under the ticker PAYO on NASDAQ, currently boasts a market capitalization of approximately $1.9 billion. On February

Read
FIX, CVNA & CRH Earn S&P 500 Inclusion After 2025 Surge
Investing

FIX, CVNA & CRH Earn S&P 500 Inclusion After 2025 Surge

FIX, CVNA, CRH Join S&P 500 After Stellar 2025 Gains The S&P 500 Index stands as the premier benchmark for

Read
AI Stocks Face Intense Selling Pressure Amid Pullback
Investing

AI Stocks Face Intense Selling Pressure Amid Pullback

Summary of Market Dynamics in AI Sector Several prominent stocks closely associated with artificial intelligence have experienced significant volatility and

Read
Virtus KAR Mid-Cap Core Q4 2025 Review (VIMCX)
Investing

Virtus KAR Mid-Cap Core Q4 2025 Review (VIMCX)

Performance Overview The Virtus KAR Mid-Cap Core Fund (VIMCX), specifically the Class I shares, recorded a return of -2.44% over

Read
Buffett’s Last Moves: Sells Amazon, Apple, BofA; Buys NYT Stock Pre-Retirement
Investing

Buffett’s Last Moves: Sells Amazon, Apple, BofA; Buys NYT Stock Pre-Retirement

The Oracle of Omaha’s Final Quarter as Berkshire Hathaway CEO Quarterly Form 13F filings submitted to the Securities and Exchange

Read
Vertex Pharmaceuticals: Resilient Biotech for Any Market Downturn
Investing

Vertex Pharmaceuticals: Resilient Biotech for Any Market Downturn

Vertex Pharmaceuticals possesses the financial strength and revenue potential to thrive regardless of prevailing market conditions. Although Vertex Pharmaceuticals (NASDAQ:

Read
How Boring Investors Outperform Over Time
Investing

How Boring Investors Outperform Over Time

Investing in the stock market often involves significant volatility, with share prices fluctuating wildly from one day to the next,

Read
Nebius Group: Key Risks Lurk in the Details
Investing

Nebius Group: Key Risks Lurk in the Details

Nebius Group’s Q4 Performance and Future Outlook Nebius Group N.V. has recently released an impressive Q4 earnings report that underscores

Read
Is D-Wave Quantum Stock Worth Buying Before Earnings?
Investing

Is D-Wave Quantum Stock Worth Buying Before Earnings?

D-Wave Quantum, trading under the ticker QBTS on the NYSE, emerged as one of the most exciting players in the

Read